Role of lipid peroxidation-derived α, β -unsaturated aldehydes in vascular dysfunction

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Lee, Seung Eun ^a   Park, Yong Seek ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR FUNCTION; CYCLOOXYGENASE 2; ENDOTHELIAL DYSFUNCTION; LIPID PEROXIDATION; METABOLIC ACTIVATION; REDOX-SENSITIVE MECHANISM; UNSATURATED ALDEHYDES; VASCULAR DISEASE;

CHEMICAL COMPOUNDS; LIPIDS; OXIDATIVE STRESS; PATHOLOGY;

ALDEHYDES;

4 HYDROXYNONENAL; ACROLEIN; ALDEHYDE; ALPHA BETA UNSATURATED ALDEHYDE; CROTONALDEHYDE; CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEOPHILE; UNCLASSIFIED DRUG;

CELL FUNCTION; DNA ADDUCT; ELECTROPHILIC STRESS; ENDOTHELIAL DYSFUNCTION; HUMAN; LIPID PEROXIDATION; METABOLIC ACTIVATION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; VASCULAR DISEASE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ALDEHYDES; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; LIPID PEROXIDATION; MODELS, BIOLOGICAL; VASCULAR DISEASES;

EID: 84879399842     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/629028     Document Type: Review

References (72)

1. Stocker R., Keaney J. F. Jr., Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004 84 4 1381 1478 2-s2.0-4644310560 10.1152/physrev.00047.2003
2. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J., Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet 2006 367 9524 1747 1757 2-s2.0-33646799069 10.1016/S0140-6736(06)68770-9
3. Sevinç S., Akyol A. D., Cardiac risk factors and quality of life in patients with coronary artery disease. Journal of Clinical Nursing 2010 19 9-10 1315 1325 2-s2.0-77955874689 10.1111/j.1365-2702.2010.03220.x
4. Sonta T., Inoguchi T., Tsubouchi H., Sekiguchi N., Kobayashi K., Matsumoto S., Utsumi H., Nawata H., Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radical Biology and Medicine 2004 37 1 115 123 2-s2.0-2942562273 10.1016/j.freeradbiomed.2004.04.001
5. Negre-Salvayre A., Coatrieux C., Ingueneau C., Salvayre R., Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. British Journal of Pharmacology 2008 153 1 6 20 2-s2.0-37849013375 10.1038/sj.bjp.0707395
6. Uchida K., Role of reactive aldehyde in cardiovascular diseases. Free Radical Biology and Medicine 2000 28 12 1685 1696 2-s2.0-0034659147 10.1016/S0891-5849(00)00226-4
7. Chen L., Na R., Gu M., Richardson A., Ran Q., Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. Journal of Neurochemistry 2008 107 1 197 207 2-s2.0-51849150799 10.1111/j.1471-4159.2008.05603.x
8. Rahman I., Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochemistry and Biophysics 2005 43 1 167 188 2-s2.0-23244438717 10.1385/CBB:43:1:167
9. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G. E., Pamplona R., Poli G., Portero-Otin M., Riahi Y., Salvayre R., Sasson S., Serrano J., Shamni O., Siems W., Siow R. C. M., Wiswedel I., Zarkovic K., Zarkovic N., Pathological aspects of lipid peroxidation. Free Radical Research 2010 44 10 1125 1171 2-s2.0-77956574773 10.3109/10715762.2010.498478
10. Szapacs M. E., Kim H. H., Porter N. A., Liebler D. C., Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe. Journal of Proteome Research 2008 7 10 4237 4246 2-s2.0-55949122145 10.1021/pr8001222
11. Mattson M. P., Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Experimental Gerontology 2009 44 10 625 633 2-s2.0-70349236876 10.1016/j.exger.2009.07.003
12. Finkelstein E. I., Ruben J., Koot C. W., Hristova M., Van Der Vliet A., Regulation of constitutive neutrophil apoptosis by the α β-unsaturated aldehydes acrolein and 4-hydroxynonenal. American Journal of Physiology 2005 289 6 L1019 L1028 2-s2.0-27944450459 10.1152/ajplung.00227.2005
13. Marnett L. J., Riggins J. N., West J. D., Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. Journal of Clinical Investigation 2003 111 5 583 593 2-s2.0-0037373455 10.1172/JCI200318022
14. LoPachin R. M., Gavin T., Petersen D. R., Barber D. S., Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chemical Research in Toxicology 2009 22 9 1499 1508 2-s2.0-70349492687 10.1021/tx900147g
15. Minko I. G., Kozekov I. D., Harris T. M., Rizzo C. J., Lloyd R. S., Stone M. P., Chemistry and biology of DNA containing 1,N2-deoxyguanosine adducts of the α β -unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chemical Research in Toxicology 2009 22 5 759 778 2-s2.0-67649933847 10.1021/tx9000489
16. Lopachin R. M., Barber D. S., Gavin T., Molecular mechanisms of the conjugated α β -unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicological Sciences 2008 104 2 235 249 2-s2.0-42149161725 10.1093/toxsci/kfm301
17. Calingasan N. Y., Uchida K., Gibson G. E., Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. Journal of Neurochemistry 1999 72 2 751 756 2-s2.0-0032905632 10.1046/j.1471-4159.1999. 0720751.x
18. Tsakadze N. L., Srivastava S., Awe S. O., Adeagbo A. S. O., Bhatnagar A., D'Souza S. E., Acrolein-induced vasomotor responses of rat aorta. American Journal of Physiology 2003 285 2 H727 H734 2-s2.0-0037962196
19. Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N., Niki E., Acrolein is a product of lipid peroxidation reaction: formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. Journal of Biological Chemistry 1998 273 26 16058 16066 2-s2.0-0032568935 10.1074/jbc.273.26.16058
20. Hamann K., Durkes A., Ouyang H., Uchida K., Pond A., Shi R., Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. Journal of Neurochemistry 2008 107 3 712 721 2-s2.0-53749101143 10.1111/j.1471-4159.2008.05622.x
21. Park Y. S., Kim J., Misonou Y., Takamiya R., Takahashi M., Freeman M. R., Taniguchi N., Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 6 1319 1325 2-s2.0-34249276068 10.1161/ATVBAHA.106.132837
22. Lee S. E., Lee S. H., Ryu D. S., Park C., Park K., Park Y. S., Differentially-expressed genes related to atherosclerosis in acrolein-stimulated human umbilical vein endothelial cells. Biochip Journal 2010 4 4 264 271 2-s2.0-79959688638 10.1007/s13206-010-4402-7
23. Conklin D. J., Bhatnagar A., Cowley H. R., Johnson G. H., Wiechmann R. J., Sayre L. M., Trent M. B., Boor P. J., Acrolein generation stimulates hypercontraction in isolated human blood vessels. Toxicology and Applied Pharmacology 2006 217 3 277 288 2-s2.0-33845187508 10.1016/j.taap.2006.09.009
24. McCall M. R., Tang J. Y., Bielicki J. K., Forte T. M., Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 10 1599 1606 2-s2.0-0029157514
25. Alfredsson L., Hammar N., Hogstedt C., Incidence of myocardial infarction and mortality from specific causes among bus drivers in Sweden. International Journal of Epidemiology 1993 22 1 57 61 2-s2.0-0027476467
26. Stonez M. P., Cho Y., Huang H., Kim H., Kozekov I. D., Kozekova A., Wang H., Minko I. G., Lloyd R. S., Harris T. M., Rizzo C. J., Interstrand DNA cross-links induced by α β -unsaturated aldehydes derived from lipid peroxidation and environmental sources. Accounts of Chemical Research 2008 41 7 793 804 2-s2.0-49049091162 10.1021/ar700246x
27. Eder E., Budiawan B., Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of TD50 and comparison with 1,N2-propanodeoxyguanosine adduct levels. Cancer Epidemiology Biomarkers and Prevention 2001 10 8 883 888 2-s2.0-0034902425
28. Kawaguchi-Niida M., Shibata N., Morikawa S., Uchida K., Yamamoto T., Sawada T., Kobayashi M., Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain. Acta Neuropathologica 2006 111 5 422 429 2-s2.0-33646252931 10.1007/s00401-006-0044-1
29. Eder E., Schuler D., Budiawan B., Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. IARC Scientific Publications 1999 150 219 232 2-s2.0-0033255256
30. Neudecker T., Eder E., Deininger C., Henschler D., Crotonaldehyde is mutagenic in Salmonella typhimurium TA100. Environmental and Molecular Mutagenesis 1989 14 3 146 148 2-s2.0-0024414761
31. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6
32. Van Der Toorn M., Smit-de Vries M. P., Slebos D., De Bruin H. G., Abello N., Van Oosterhout A. J. M., Bischoff R., Kauffman H. F., Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. American Journal of Physiology 2007 293 5 L1156 L1162 2-s2.0-36348987864 10.1152/ajplung.00081. 2007
33. Liu X., Yang Z., Pan X., Zhu M., Xie J., Crotonaldehyde induces oxidative stress and caspase-dependent apoptosis in human bronchial epithelial cells. Toxicology Letters 2010 195 1 90 98 2-s2.0-77951924602 10.1016/j.toxlet.2010.02. 004
34. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T., Activation of stress signaling pathways by the end product of lipid peroxidation: 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. Journal of Biological Chemistry 1999 274 4 2234 2242 2-s2.0-0033593225 10.1074/jbc.274.4.2234
35. Kode A., Yang S., Rahman I., Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respiratory Research 2006 7 article 132 2-s2.0-33750949369 10.1186/1465-9921-7- 132
36. Kumagai T., Matsukawa N., Kaneko Y., Kusumi Y., Mitsumata M., Uchida K., A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. Journal of Biological Chemistry 2004 279 46 48389 48396 2-s2.0-9144219652 10.1074/jbc.M409935200
37. Butterfield D. A., Bader Lange M. L., Sultana R., Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochimica et Biophysica Acta 2010 1801 8 924 929 2-s2.0-77953257870 10.1016/j.bbalip.2010.02.005
38. Rahman I., Van Schadewijk A. A. M., Crowther A. J. L., Hiemstra P. S., Stolk J., MacNee W., De Boer W. I., 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2002 166 4 490 495 2-s2.0-0037102347 10.1164/rccm.2110101
39. Quinlan G. J., Evans T. W., Gutteridge J. M. C., 4-Hydroxy-2-nonenal levels increase in the plasma of patients with adult respiratory distress syndrome as linoleic acid appears to fall. Free Radical Research 1994 21 2 95 106 2-s2.0-0028486019
40. Napoli C., D'Armiento F. P., Mancini F. P., Postiglione A., Witztum J. L., Palumbo G., Palinski W., Fatty streak formation occurs in human fetal aortas and is greatly enhanced maternal, hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atheroeclerotic lesions. Journal of Clinical Investigation 1997 100 11 2680 2690 2-s2.0-0031456505
41. Lovell M. A., Xie C., Markesbery W. R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiology of Aging 2001 22 2 187 194 2-s2.0-0035112495 10.1016/S0197-4580(00) 00235-9
42. Bradley M. A., Markesbery W. R., Lovell M. A., Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology and Medicine 2010 48 12 1570 1576 2-s2.0-77952672909 10.1016/j.freeradbiomed.2010.02.016
43. Uesugi N., Sakata N., Nangaku M., Abe M., Horiuchi S., Hisano S., Iwasaki H., Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. American Journal of Kidney Diseases 2004 44 2 224 238 2-s2.0-3242709799 10.1053/j.ajkd.2004.04.027
44. Grigsby J., Betts B., Vidro-Kotchan E., Culbert R., Tsin A., A possible role of acrolein in diabetic retinopathy: involvement of a VEGF/TGFbeta signaling pathway of the retinal pigment epithelium in hyperglycemia. Current Eye Research 2012 37 11 1045 1053
45. Srivastava S., Sithu S. D., Vladykovskaya E., Haberzettl P., Hoetker D. J., Siddiqui M. A., Conklin D. J., D'Souza S. E., Bhatnagar A., Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011 215 2 301 308 2-s2.0-79953049789 10.1016/j.atherosclerosis.2011.01.001
46. Wang T., Liu Y., Chen L., Wang X., Hu X.-., Feng Y.-., Liu D.-., Xu D., Duan Y.-., Lin J., Ou X.-., Wen F.-., Effect of sildenafil on acrolein-induced airway inflammation and mucus production in rats. European Respiratory Journal 2009 33 5 1122 1132 2-s2.0-66749145510 10.1183/09031936.00055908
47. Volpi G., Facchinetti F., Moretto N., Civelli M., Patacchini R., Cigarette smoke and α β -unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. British Journal of Pharmacology 2011 163 3 649 661 2-s2.0-79955880483 10.1111/j.1476-5381.2011.01253.x
48. Tsirulnikov K., Abuladze N., Bragin A., Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal. Toxicology and Applied Pharmacology 2012 263 3 303 314
49. Eaton P., Li J., Hearse D. J., Shattock M. J., Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. American Journal of Physiology 1999 276 3 H935 H943 2-s2.0-0032921371
50. Leonarduzzi G., Chiarpotto E., Biasi F., Poli G., 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Molecular Nutrition and Food Research 2005 49 11 1044 1049 2-s2.0-28444442268 10.1002/mnfr.200500090
51. Halliwell B., Poulsen H. E., Cigarette Smoke and Oxidative Stress 2006 Berlin, Germany Springer
52. Park Y. S., Misonou Y., Fujiwara N., Takahashi M., Miyamoto Y., Koh Y. H., Suzuki K., Taniguchi N., Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 2005 327 4 1058 1065 2-s2.0-12344329415 10.1016/j.bbrc.2004.12.104
53. Lee S. E., Jeong S. I., Kim G., Yang H., Park C., Jin Y., Park Y. S., Upregulation of heme oxygenase-1 as an adaptive mechanism for protection against crotonaldehyde in human umbilical vein endothelial cells. Toxicology Letters 2011 201 3 240 248 2-s2.0-79951767414 10.1016/j.toxlet.2011.01.006
54. Adams J. D. Jr., Klaidman L. K., Acrolein-induced oxygen radical formation. Free Radical Biology and Medicine 1993 15 2 187 193 2-s2.0-0027227808 10.1016/0891-5849(93)90058-3
55. Kehrer J. P., Biswal S. S., The molecular effects of acrolein. Toxicological Sciences 2000 57 1 6 15 2-s2.0-0033864802
56. Whitsett J., Picklo M. J. Sr., Vasquez-Vivar J., 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 11 2340 2347 2-s2.0-36048937528 10.1161/ATVBAHA.107. 153742
57. Yun M. R., Park H. M., Seo K. W., Lee S. J., Im D. S., Kim C. D., 5-Lipoxygenase plays an essential role in 4-HNE-enhanced ROS production in murine macrophages via activation of NADPH oxidase. Free Radical Research 2010 44 7 742 750 2-s2.0-77953334791 10.3109/10715761003758122
58. Foncea R., Carvajal C., Almarza C., Leighton F., Endothelial cell oxidative stress and signal transduction. Biological Research 2000 33 2 89 96 2-s2.0-0347252674
59. Nguyen T., Yang C. S., Pickett C. B., The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radical Biology and Medicine 2004 37 4 433 441 2-s2.0-3142570440 10.1016/j.freeradbiomed.2004.04.033
60. Miyamoto Y., Koh Y. H., Park Y. S., Fujiwara N., Sakiyama H., Misonou Y., Ookawara T., Suzuki K., Honke K., Taniguchi N., Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biological Chemistry 2003 384 4 567 574 2-s2.0-0037621502 10.1515/BC.2003.064
61. Misonou Y., Takahashi M., Park Y. S., Asahi M., Miyamoto Y., Sakiyama H., Cheng X., Taniguchi N., Acrolein induces Hsp72 via both PKC δ /JNK and calcium signaling pathways in human umbilical vein endothelial cells. Free Radical Research 2005 39 5 507 512 2-s2.0-19044372146 10.1080/10715760500072255
62. Lee N. J., Lee S. E., Lee S. H., Ryu D. S., Park Y. S., Acrolein induces adaptive response through upregulate of HO-1 via activation of Nrf2 in RAW 264. 7 macrophage. Molecular & Cellular Toxicology 2009 5 3 77
63. Wu C. C., Hsieh C. W., Lai P. H., Lin J. B., Liu Y. C., Wung B. S., Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicology and Applied Pharmacology 2006 214 3 244 252 2-s2.0-33745986025 10.1016/j.taap.2005. 12.013
64. Ishikado A., Nishio Y., Morino K., Ugi S., Kondo H., Makino T., Kashiwagi A., Maegawa H., Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochemical and Biophysical Research Communications 2010 402 1 99 104 2-s2.0-78049269927 10.1016/j.bbrc.2010.09.124
65. Park Y. S., Taniguchi N., Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Annals of the New York Academy of Sciences 2008 1126 185 189 2-s2.0-42549159857 10.1196/annals.1433.034
66. Li L., Hamilton R. F. Jr., Holian A., Effect of acrolein on human alveolar macrophage NF- B activity. American Journal of Physiology 1999 277 3 L550 L557 2-s2.0-0032886989
67. Haberzettl P., Vladykovskaya E., Srivastava S., Bhatnagar A., Role of endoplasmic reticulum stress in acrolein-induced endothelial activation. Toxicology and Applied Pharmacology 2009 234 1 14 24 2-s2.0-57149117113 10.1016/j.taap.2008.09.019
68. Lee S. J., Kim C. E., Seo K. W., Kim C. D., HNE-induced 5-LO expression is regulated by NF- B/ERK and Sp1/p38 MAPK pathways via EGF receptor in murine macrophages. Cardiovascular Research 2010 88 2 352 359 2-s2.0-77958081965 10.1093/cvr/cvq194
69. Burleigh M. E., Babaev V. R., Oates J. A., Harris R. C., Gautam S., Riendeau D., Marnett L. J., Morrow J. D., Fazio S., Linton M. F., Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 2002 105 15 1816 1823 2-s2.0-0037117652 10.1161/01.CIR.0000014927.74465.7F
70. O'Toole T. E., Zheng Y., Hellmann J., Conklin D. J., Barski O., Bhatnagar A., Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages. Toxicology and Applied Pharmacology 2009 236 2 194 201 2-s2.0-62549138221 10.1016/j.taap.2009.01.024
71. Kim C. E., Lee S. J., Seo K. W., Park H. M., Yun J. W., Bae J. U., Bae S. S., Kim C. D., Acrolein increases 5-lipoxygenase expression in murine macrophages through activation of ERK pathway. Toxicology and Applied Pharmacology 2010 245 1 76 82 2-s2.0-77952549595 10.1016/j.taap.2010.02.003
72. Akiba S., Kumazawa S., Yamaguchi H., Hontani N., Matsumoto T., Ikeda T., Oka M., Sato T., Acceleration of matrix metalloproteinase-1 production and activation of platelet-derived growth factor receptor β in human coronary smooth muscle cells by oxidized LDL and 4-hydroxynonenal. Biochimica et Biophysica Acta 2006 1763 8 797 804 2-s2.0-33746951927 10.1016/j.bbamcr.2006.06. 003